Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

被引：0
|
作者：
Mitra Mohit
Zahra Sarraf
Gelavizh Sheikhi
Minoo Robati
Amir Vasheghani-Farahani
机构：
[1] Shiraz University of Medical Sciences,Department of Obstetrics and Gynecology
[2] Islamic Azad University,Department of Obstetrics and Gynecology
[3] Medical Sciences Branch of Tehran,Department of Obstetrics and Gynecology
[4] Booali Hospital,undefined
来源：
Archives of Gynecology and Obstetrics | 2009年 / 280卷
关键词：
Gestational trophoblastic neoplasia; Low-risk gestational trophoblastic neoplasia (LRGTN); Single-agent chemotherapy; Methotrexate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：775 / 780
页数：5
相关论文
共 50 条
  • [41] Management of low-risk gestational trophoblastic neoplasia in indigent women
    Schorge, JO
    Lea, JS
    Farrar, DF
    King, MR
    Coleman, RL
    Miller, DS
    JOURNAL OF REPRODUCTIVE MEDICINE, 2003, 48 (10) : 780 - 784
  • [42] Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
    Lybol, C.
    Sweep, F. C. G. J.
    Harvey, R.
    Mitchell, H.
    Short, D.
    Thomas, C. M. G.
    Ottevanger, P. B.
    Savage, P. M.
    Massuger, L. F. A. G.
    Seckl, M. J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 576 - 579
  • [43] Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia
    Osborne, Raymond J.
    Filiaci, Virginia L.
    Schink, Julian C.
    Mannel, Robert S.
    Behbakht, Kian
    Hoffman, James S.
    Spirtos, Nick M.
    Chan, John K.
    Tidy, John A.
    Miller, David S.
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (03): : 535 - 542
  • [44] Low-risk gestational trophoblastic disease: Is more methotrexate better?
    Myers, T. K.
    Elfrink, S. H.
    Elder, J. W.
    Kimball, K. J.
    Hurt, J. D.
    Richardson, D. L.
    Ballard, K. S.
    Homesley, H. D.
    Cohn, D. E.
    Barnes, M. N.
    McMeekin, D. S.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S5 - S6
  • [45] Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?
    Poli, Juliana Gomes
    Paiva, Gabriela
    Freitas, Fernanda
    Mora, Paulo
    Coca Velarde, Luis Guillermo
    Amim Junior, Joffre
    Rezende Filho, Jorge
    Elias, Kevin M.
    Horowitz, Neil S.
    Braga, Antonio
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 638 - 644
  • [46] Low-Risk Gestational Trophoblastic Neoplasia and Methotrexate Resistance Predictors of Response to Treatment with Actinomycin D and Need for Combination Chemotherapy
    Growdon, Whitfield B.
    Wolfberg, Adam J.
    Goldstein, Donald P.
    Feltmate, Colleen M.
    Chinchilla, Manuel E.
    Lieberman, Ellice S.
    Berkowitz, Ross S.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2010, 55 (7-8) : 279 - 284
  • [47] METHOTREXATE WITH CITROVORUM FACTOR IN LOW-RISK GESTATIONAL TROPHOBLASTIC TUMOR
    BOLIS, G
    COLOMBO, N
    EPIS, A
    MANGILI, G
    VASSENA, L
    VERGADORO, F
    BELLONI, C
    TUMORI, 1987, 73 (03) : 309 - 313
  • [48] The endoglin-BMP9 axis as a predictor of methotrexate resistance in low-risk gestational trophoblastic neoplasia
    Elias, Kevin M.
    Hasselblatt, Kathleen T.
    Harvey, Richard A.
    Berkowitz, Ross S.
    Seckl, Michael J.
    Horowitz, Neil S.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 407 - 407
  • [49] Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone
    Couder, Florence
    Massardier, Jerome
    You, Benoit
    Abbas, Fatima
    Hajri, Touria
    Lotz, Jean-Pierre
    Schott, Anne-Marie
    Golfier, Francois
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (01) : 80.e1 - 80.e7
  • [50] Methotrexate Gestational Patients: for 2000 FIGO Low-Risk Gestational Trophoblastic Neoplasia Patients: Efficacy and Toxicity EDITORIAL COMMENT
    Chalouhi, Gihad Elias
    Golfier, Francois
    Soignon, Pauline
    Massardier, Jerome
    Guastalla, Jean-Paul
    Trillet-Lenoir, Veronique
    Schott, Anne-Marie
    Raudrant, Daniel
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2009, 64 (11) : 724 - 725
12345